These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31319131)

  • 1. AMPK as a potential pharmacological target for alleviating LPS-induced acute lung injury partly via NLRC4 inflammasome pathway inhibition.
    He Y; Xu K; Wang Y; Chao X; Xu B; Wu J; Shen J; Ren W; Hu Y
    Exp Gerontol; 2019 Oct; 125():110661. PubMed ID: 31319131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tangeretin attenuates acute lung injury in septic mice by inhibiting ROS-mediated NLRP3 inflammasome activation via regulating PLK1/AMPK/DRP1 signaling axis.
    Liu Y; Zhang Y; You G; Zheng D; He Z; Guo W; Antonina K; Shukhrat Z; Ding B; Zan J; Zhang Z
    Inflamm Res; 2024 Jan; 73(1):47-63. PubMed ID: 38147126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
    Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
    Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
    Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
    J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
    Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buformin alleviates sepsis-induced acute lung injury via inhibiting NLRP3-mediated pyroptosis through an AMPK-dependent pathway.
    Liu B; Wang Z; He R; Xiong R; Li G; Zhang L; Fu T; Li C; Li N; Geng Q
    Clin Sci (Lond); 2022 Feb; 136(4):273-289. PubMed ID: 35132999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total tanshinones protect against acute lung injury through the PLCγ2/NLRP3 inflammasome signaling pathway.
    Li X; Qiu H; Gan J; Liu Z; Yang S; Yuan R; Gao H
    J Ethnopharmacol; 2023 Oct; 314():116478. PubMed ID: 37121449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
    Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
    Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
    Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
    Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages.
    Zhou Y; Zhang CY; Duan JX; Li Q; Yang HH; Sun CC; Zhang J; Luo XQ; Liu SK
    Biomed Pharmacother; 2020 Jan; 121():109596. PubMed ID: 31731193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.
    Zhang H; Chen S; Zeng M; Lin D; Wang Y; Wen X; Xu C; Yang L; Fan X; Gong Y; Zhang H; Kong X
    Cell Physiol Biochem; 2018; 49(5):1918-1932. PubMed ID: 30235451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
    Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
    Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of pteryxin on LPS-induced acute lung injury via modulating MAPK/NF-κB pathway and NLRP3 inflammasome activation.
    Xuan TQ; Gong G; Du H; Liu C; Wu Y; Bao G; Ma Q; Zhen D
    J Ethnopharmacol; 2022 Mar; 286():114924. PubMed ID: 34942323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway.
    Lu Y; Yu T; Liu J; Gu L
    PLoS One; 2018; 13(4):e0196405. PubMed ID: 29694408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of long non-coding RNA MEG3 alleviates lipopolysaccharide-induced acute lung injury by acting as a molecular sponge of microRNA-7b to modulate NLRP3.
    Liao H; Zhang S; Qiao J
    Aging (Albany NY); 2020 Aug; 12(20):20198-20211. PubMed ID: 32852284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
    Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
    Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-chemically Modified Tetracycline-3 (nCMT-3) Attenuates Acute Lung Injury via Blocking sTREM-1 Release and NLRP3 Inflammasome Activation.
    Meng Q; Wang X; Guo D; Shi C; Gu R; Ma J; Nieman G; Kollisch-Singule M; Luo J; Cooney RN
    Shock; 2022 May; 57(5):749-758. PubMed ID: 35583915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-delivered angiopoietin-1 ameliorates phosgene-induced acute lung injury via inhibition of NLRP3 inflammasome activation.
    He DK; Chen JF; Shao YR; Zhou FQ; Shen J
    Inhal Toxicol; 2018; 30(4-5):187-194. PubMed ID: 30257148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways.
    Yang H; Lv H; Li H; Ci X; Peng L
    Cell Commun Signal; 2019 Jun; 17(1):62. PubMed ID: 31186013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Andrographolide Derivative AL-1 Ameliorates LPS-induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome and Lung Permeability.
    Li T; Zhang C; Wei Y; Zhong H; Shan L; Yu P; Wang Y; Xu L
    Curr Pharm Des; 2022; 28(30):2508-2517. PubMed ID: 35909279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.